C, E. et al. 2019. PREVALANE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies. 34, (Jul. 2019), 21. DOI:https://doi.org/10.15605/jafes.034.S29.